Tag: covid

COVID-19 Vaccines Don’t Cause Infertility of Harm Pregnancy Chances, BU Research Shows
Health

COVID-19 Vaccines Don’t Cause Infertility of Harm Pregnancy Chances, BU Research Shows

Getting the COVID-19 vaccine does not impact chances of conceiving. However, getting the virus can reduce male fertility. Researchers at the Boston University School of Public Health were unable to find a link between failure to conceive in men or women that Pfizer, Moderna, or the Johnson and Johnson vaccines. Doing research has proven that the fertility rates who received one dose were nearly identical to the unvaccinated female participants. Men that tested positive for COVID had reduced fertility compared to men who never tested positive. The findings in research about the link between fertility and the virus should be reassuring to those that believe vaccination affects fertility. Anecdotal reports that claim women’s periods are affected by the vaccine have been debunked by research ...
New Covid data show New York returning to pre-Omicron surge levels
Health

New Covid data show New York returning to pre-Omicron surge levels

As COVID numbers begin to dwindle, New York begins to consider relaxing pandemic restrictions. The governor announced that a mere 3,883 people within the state were hospitalized in one day, which is a new low. When compared to the positivity rate a year ago, the rate has fallen by 20.5%. While the decline in numbers is a good sign, this is not the time to let up. New Yorkers are still urged to get vaccinated if they are five years and older. To learn more, click here.
COVID-19 will continue but the end of the pandemic is near
Health

COVID-19 will continue but the end of the pandemic is near

As of January 17, 2022 there were more than ten times the infections during the peak of the delta wave in April 2021. This unprecedented level of infection leads experts to believe that more than 50% of the world will have been infected with omicron by March, 2022. IHME models suggest that increasing mask use, expanding vaccination coverage, and delivering third doses of the vaccine will have a very limited impact on the course of the omicron wave. Although this virus shows no signs of disappearing, it is expected that there will be a period of weeks or months where the world will experience low levels of virus transmission. To learn more, click here.
Biden acknowledges frustration with Covid rules, but says lifting mask mandates is ‘premature.’
Health

Biden acknowledges frustration with Covid rules, but says lifting mask mandates is ‘premature.’

President Biden acknowledges the American concerns with indoor mask mandates. While it may be considered too early to lift the mandate, he states that other mandates will be able to end instead. According to a CBS poll, the majority of Americans actually support mask mandates, however, they are still very frustrated by the pandemic. While experts agree that mask requirements in schools should not last forever, if they are lifted too early, that can jeopardize the progress that has been made over the past months. As rates of childhood vaccination increase, schools may even be able to end their own mandates. To learn more, click here.
Sweden recommends fourth COVID vaccine dose to older people
Health

Sweden recommends fourth COVID vaccine dose to older people

It is now recommended that individuals over 80 years old and those that live in nursing homes or get home care receive a fourth COVID vaccine shot. The Swedish Public Health Agency believes that this shot will strengthen protection against severe disease. Sweden has had very “off-hands” approach to the pandemic. They are one of the only Europeans countries that never went into lockdown or closed businesses. Instead, they consider it a personal responsibility to handle the pandemic in the best way possible. To learn more, click here.
Coronavirus (COVID 19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine
Health

Coronavirus (COVID 19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine

As of 1/03/2022, the FDA amended the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine in order to expand the use of a single booster dose, shorten the time between vaccine completion and booster, and allow for a third primary series dose. Boosters are now available to those that are 12 years and older. The booster interval is now updated to five months for those that are 12 years and older. All children from the ages of 5 to 11 who are immunocompromised have been approved for a third primary series dose if they fulfill the requirements. The booster dose for the authorized vaccines provide better protection from the delta and omicron variants. Most common side effects after receiving the booster shot is as follows: redness and swelling at the injection site, fatigue, he...
Coronavirus (COVID 19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
Health

Coronavirus (COVID 19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

As new data on COVID-19 emerges, the FDA has revised the authorizations for two monoclonal antibody treatments that are administered together: bamlanivimab and etesevimab. These may only be used when the patient is likely to have already been infected with or exposed to a variant that is susceptible to the aforementioned treatments. Monoclonal antibodies are lab made proteins. COVID-19 can mutate over time, which is why this update is necessary. These treatments do not count as a substitute for getting vaccinated. Data clearly shows that receiving the vaccine along with a booster shot is still the best way to lower the risk of contracting COVID-19 and experiencing the possible life threatening symptoms that come along with it. To learn more, click here.
COVID-19 vaccines: 76% of reported side effects may be due to ‘nocebo’ effect.
Health

COVID-19 vaccines: 76% of reported side effects may be due to ‘nocebo’ effect.

A placebo, also known as a substance without medical effects, is being used to study the reliability of reported effects of COVID-19. A recent study found that 35.2% of trial participants who received a saline solution instead of an actual vaccine against COVID-19 reported at least one adverse reaction. Those that received a vaccine and reported placebo-based symptoms demonstrated a nocebo response. During the trial, it was also found that when given a second dose, reported adverse effects went up from 46% to 61%, and the adverse effects for placebo recipients decreased from 35% to 32%. The facts that we have about placebos makes this information unsurprising. To learn more, click here.
FDA authorizes new antibody treatment to fight omicron
Health

FDA authorizes new antibody treatment to fight omicron

Recently, the FDA has authorized a new drug called bebtelovimab, a monoclonal therapy for COVID-19 patients.  Patients as young as 12 that are high risk for sever illness can take this drug to prevent getting sicker or even end up in the hospital. Due to a shortage on drugs that have been proven effective in fighting the omicron variant, professionals have been faced with the difficult decision on who should receive the treatment. The latest authorization brings the total number of treatments for omicron to four. To learn more, click here.
FDA postpones review of Pfizer data on vaccine for kids under 5
Health

FDA postpones review of Pfizer data on vaccine for kids under 5

After reviewing data, Dr. Peter Marks, the FDA’S vaccine chief, tells reporters that “at this time, it makes sense for us to wait until we have the data from the evaluation of a third dose before taking action.” Pfizer applied for an emergency use authorization for its vaccine for children aged 6 months to 4 years. Scientists continue to research a three-shot regimen, which may ultimately be the most effective vaccine regimen for children of that age group. Currently, the dosage for children 5 and under is only one tenth of the current dose for adults. Pfizer supports the idea of a three dose booster due to the data shown by other age groups. The estimated time to submit data on the third dose is early April. To learn more, click here.